19 April, 2021

Is This The Most Undervalued and Highest Growth ASX-Listed Cannabis Stock?

14 April, 2021

ECS Botanics flags major initiative to make Tasmania the ‘global epicentre’ of medical cannabis production

12 April, 2021

Releaf Group’s Gary Mackenzie Talks Medical Cannabis Prescriptions in Australia

26 March, 2021

ECS Botanics’ new subsidiary extends supply agreement for its sun-kissed cannabis flower

16 March, 2021

Strategic moves in cannabis – ECS’s giant leapfrog puts it ahead of the game

3 March, 2021

ECS Botanics integrates vertically with acquisition of Murray Meds

24 December, 2020

ECS Botanics poised to benefit from shift to ‘cannabis phase two’

17 December, 2020

ECS Botanics raises $4 million to fund medicinal cannabis facility in Tasmania

23 November, 2020

Cannabis company ECS Botanics set to benefit majorly from newly announced regulatory changes